Larvol Delta - Impact-of-2-Years-of-Bimekizumab-Treatment-on-MRI-Inflammatory-and-Structural-Lesions-in-the-Sacroiliac-Joints-of-Patients-with-NonRadiographic-Axial-Spondyloarthritis-An-Integrated-Analysis-from-a-Phase-3-Study-and-its-OpenLabel-Extension

Bimzelx (bimekizumab-bkzx) - UCB

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1899081&mode=presInfo

Walter P P. Maksymowych, MD, FRCPC, MRCP, FACP

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next